DE2605469C3 - Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff - Google Patents

Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff

Info

Publication number
DE2605469C3
DE2605469C3 DE2605469A DE2605469A DE2605469C3 DE 2605469 C3 DE2605469 C3 DE 2605469C3 DE 2605469 A DE2605469 A DE 2605469A DE 2605469 A DE2605469 A DE 2605469A DE 2605469 C3 DE2605469 C3 DE 2605469C3
Authority
DE
Germany
Prior art keywords
fraction
rabies virus
cleavage product
cleavage
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2605469A
Other languages
German (de)
English (en)
Other versions
DE2605469A1 (de
DE2605469B2 (de
Inventor
James H. Dr. 7400 Tuebingen Cox
Bernhard Dr. 7403 Ammerbuch Dietzschold
Lothar G. Dr. 7400 Tuebingen Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE2605469A priority Critical patent/DE2605469C3/de
Priority to FR7703023A priority patent/FR2340955A1/fr
Priority to NL7701255A priority patent/NL7701255A/xx
Priority to OA56069A priority patent/OA05567A/xx
Priority to LU76737A priority patent/LU76737A1/xx
Priority to IT20166/77A priority patent/IT1075115B/it
Priority to IL51412A priority patent/IL51412A/xx
Priority to GB5495/77A priority patent/GB1567547A/en
Priority to CA271,602A priority patent/CA1087982A/en
Priority to DK59377A priority patent/DK145580C/da
Priority to CH170977A priority patent/CH638562A5/de
Priority to AT92877A priority patent/AT350715B/de
Priority to IE293/77A priority patent/IE44440B1/en
Priority to JP1353277A priority patent/JPS5299209A/ja
Priority to BE174916A priority patent/BE851404A/xx
Publication of DE2605469A1 publication Critical patent/DE2605469A1/de
Publication of DE2605469B2 publication Critical patent/DE2605469B2/de
Application granted granted Critical
Publication of DE2605469C3 publication Critical patent/DE2605469C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE2605469A 1976-02-12 1976-02-12 Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff Expired DE2605469C3 (de)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DE2605469A DE2605469C3 (de) 1976-02-12 1976-02-12 Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff
FR7703023A FR2340955A1 (fr) 1976-02-12 1977-02-03 Produit de dissociation du virus de la rage, son procede d'obtention et vaccin le contenant
NL7701255A NL7701255A (nl) 1976-02-12 1977-02-07 Splitsingsprodukt van het hondsdolheidsvirus, werkwijze voor het winnen daarvan en dit materiaal bevattende entstof.
LU76737A LU76737A1 (https=) 1976-02-12 1977-02-10
IT20166/77A IT1075115B (it) 1976-02-12 1977-02-10 Prodotto di scissione del virus rabbico,procedimento per ottenerlo e vaccino contenente detto prodotto di scissione
IL51412A IL51412A (en) 1976-02-12 1977-02-10 Fission product of rabies virus,process for its preparation and vaccine containing same
GB5495/77A GB1567547A (en) 1976-02-12 1977-02-10 Fission product of rabies virus process for its preparation and vaccine containing same
OA56069A OA05567A (fr) 1976-02-12 1977-02-10 Produit de dissociation du virus de la rage, son procédé d'obtention et vaccin le contenant.
CA271,602A CA1087982A (en) 1976-02-12 1977-02-11 Fission product of rabies virus, process for its preparation and vaccine containing same
DK59377A DK145580C (da) 1976-02-12 1977-02-11 Fremgangsmaade til isolering af et immunologisk aktivt spaltningsprodukt af hundegalskab-virus
CH170977A CH638562A5 (en) 1976-02-12 1977-02-11 Process for obtaining a cleavage product of rabies virus
AT92877A AT350715B (de) 1976-02-12 1977-02-11 Verfahren zur gewinnung eines spaltproduktes des tollwut-virus
IE293/77A IE44440B1 (en) 1976-02-12 1977-02-11 Fission product of rabies virus, proces for its preparation and vaccine containing same
JP1353277A JPS5299209A (en) 1976-02-12 1977-02-12 Production of hydrophobia virus nucear fission product
BE174916A BE851404A (fr) 1976-02-12 1977-02-14 Produit de dissociation du virus de la rage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2605469A DE2605469C3 (de) 1976-02-12 1976-02-12 Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff

Publications (3)

Publication Number Publication Date
DE2605469A1 DE2605469A1 (de) 1977-09-15
DE2605469B2 DE2605469B2 (de) 1979-08-02
DE2605469C3 true DE2605469C3 (de) 1980-04-10

Family

ID=5969649

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2605469A Expired DE2605469C3 (de) 1976-02-12 1976-02-12 Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff

Country Status (15)

Country Link
JP (1) JPS5299209A (https=)
AT (1) AT350715B (https=)
BE (1) BE851404A (https=)
CA (1) CA1087982A (https=)
CH (1) CH638562A5 (https=)
DE (1) DE2605469C3 (https=)
DK (1) DK145580C (https=)
FR (1) FR2340955A1 (https=)
GB (1) GB1567547A (https=)
IE (1) IE44440B1 (https=)
IL (1) IL51412A (https=)
IT (1) IT1075115B (https=)
LU (1) LU76737A1 (https=)
NL (1) NL7701255A (https=)
OA (1) OA05567A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070388D1 (en) * 1980-10-02 1985-05-02 Schering Corp Injectable rabies vaccine composition and method for preparing same
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.

Also Published As

Publication number Publication date
DK145580C (da) 1983-05-16
OA05567A (fr) 1981-04-30
ATA92877A (de) 1978-11-15
IT1075115B (it) 1985-04-22
BE851404A (fr) 1977-08-16
CH638562A5 (en) 1983-09-30
DK145580B (da) 1982-12-13
DE2605469A1 (de) 1977-09-15
GB1567547A (en) 1980-05-14
CA1087982A (en) 1980-10-21
FR2340955B1 (https=) 1979-03-02
JPS5299209A (en) 1977-08-19
IE44440L (en) 1977-08-12
AT350715B (de) 1979-06-11
DE2605469B2 (de) 1979-08-02
IL51412A0 (en) 1977-04-29
FR2340955A1 (fr) 1977-09-09
DK59377A (da) 1977-08-13
IL51412A (en) 1980-05-30
NL7701255A (nl) 1977-08-16
LU76737A1 (https=) 1977-08-19
IE44440B1 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
DE3001585C2 (de) Verfahren zur Herstellung von Interferon Typ I und II
DD262673A5 (de) Verfahren zur extraktion von lipolhilen proteinen aus zellen der gattung pichia
DE3641040C2 (https=)
DE3014189A1 (de) Verfahren zur herstellung eines immunogenen membranproteinaggregats von influenza-, parainfluenza- und rhabdo-viren
DE2605469C3 (de) Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff
DE3236126A1 (de) Verfahren zur herstellung von zur intravenoesen verabreichung geeignetem (gamma)-globulin
DE2619715A1 (de) Tumor-antigen und verfahren zu dessen herstellung
EP0367840A1 (de) Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
DE2259405C2 (de) Verfahren zur Gewinnung von Orgotein aus roten Blutzellen
DD211444A3 (de) Verfahren zur herstellung von influenza-impfstoffen
DE2950004C2 (de) Verfahren zur Herstellung von Frühsommer-Meningoenzephalitis-Virus(FSME-Virus)-Vakzinen
DE2333884C3 (de) Verfahren zum Herstellen von hochgereinigtem Humanalbumin
DE2508396A1 (de) Verfahren zur gewinnung von virusproteinen, die dabei erhaltenen proteine und diese proteine als wirkstoffe enthaltende arzneimittel
DE69012903T2 (de) Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
DE3323093C2 (de) Pharmazeutisches Präparat zur Bekämpfung von Tumoren
DE2447050A1 (de) Verfahren zur gewinnung von proteasenhemmstoff
DE60118409T2 (de) Herstellungsverfahren von immunglobulinen, die gegen menschliche thymozyten gerichtet sind
DE3323092A1 (de) Pharmazeutisches praeparat
EP0285752A2 (de) Kamillenöle mit hohem Gehalt an natürlichen Polyinen und Verfahren zu deren Herstellung
DD242716A3 (de) Verfahren zur herstellung von gereinigten antigenen bzw. biopraeparaten
DD228737A1 (de) Verfahren zur herstellung von influenza-inaktivimpfstoffen mit geringer stammabhaengigkeit
EP0049424B1 (de) Bioaktives, pflanzliche Wirkstoffe enthaltendes Mittel
DE2532276C3 (de) Verfahren zur Reinigung von Human-Antilymphozytenserum
DE2627721A1 (de) Verfahren zur herstellung einer total- flavonoidmischung aus pflanzlichem material
DE3421302A1 (de) Verfahren zur isolierung und reinigung von (alpha)-interferonen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee